z-logo
Premium
Coronavirus disease ( COVID ‐19): An updated review based on current knowledge and existing literature for dermatologists
Author(s) -
Kaur Ishmeet,
Sharma Aseem,
Jakhar Deepak,
Das Anupam,
Aradhya Sujala Sacchidanand,
Sharma Rashmi,
Jindal Veenu,
Mhatre Madhulika
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13677
Subject(s) - medicine , pandemic , coronavirus , pneumonia , covid-19 , disease , epidemiology , intensive care medicine , transmission (telecommunications) , public health , disease management , virology , immunology , infectious disease (medical specialty) , pathology , electrical engineering , engineering , parkinson's disease
The world entered the year 2020 with reports of the emergence of a new viral illness in Wuhan city, Hubei province, China. In January 2020, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was identified to be the causative novel coronavirus for the cluster of patients suffering from pneumonia in China. The disease was later named as coronavirus disease (COVID‐19) and was declared a pandemic by the World Health Organization on March 11, 2020. Several studies, since then, have tried to study and explain the origin of SARS‐CoV‐2, its structure and pathogenicity, epidemiology, modes of transmission, spectrum of illness and causes of mortality and morbidity. The current management strategies focus on supportive care and prevention of complications. With no definite treatment, as of now, encouraging reports of some anti‐viral and anti‐malarial drugs in the management of COVID‐19 generate some hope. This review intends to cover the current known aspects of COVID‐19 and SARS‐CoV‐19, based on the available literature.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here